Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19Jean M. Connors, Juvenal Martinez, Maria M. Brooks et al.|JAMA|2021Cited by 265
Brain Oxygen Optimization in Severe Traumatic Brain Injury (BOOST-3): a multicentre, randomised, blinded-endpoint, comparative effectiveness study of brain tissue oxygen and intracranial pressure monitoring versus intracranial pressure aloneFrançis Bernard, Lori Shutter, William G. Barsan et al.|BMJ Open|2022Cited by 136
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor–Biased Ligand in Adults With COVID-19Wesley H. Self, Peter K. Henke, Matthew S. Shotwell et al.|JAMA|2023Cited by 56
Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset HypoxemiaAri Moskowitz, Wesley H. Self, Matthew S. Shotwell et al.|CHEST Journal|2022Cited by 25
Fostamatinib for Hospitalized Adults With COVID-19 and HypoxemiaSean P. Collins, Jill M. Pulley, Krystle D. Apodaca et al.|JAMA Network Open|2024Cited by 9